Příprava protinádorové vakcíny pro pacienty s mnohočetným myelomem na bázi dendritických buněk naložených monoklonálním imunoglobulinem

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells
Authors

OČADLÍKOVÁ Darina ZAHRADOVÁ Lenka KOVÁŘOVÁ Lucie SMEJKALOVÁ Jana POUR Luděk VIDLÁKOVÁ Petra KYJOVSKÁ Drahomíra MORAVCOVÁ Jana RYCOVÁ Marcela NOVOTNÁ H. JELÍNKOVÁ I. PENKA Miroslav MICHÁLEK Jaroslav HÁJEK Roman

Year of publication 2009
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords multiple myeloma; dendritic cells; vaccine
Description On June 2006, phase II clinical trial focused on anticancer vaccination of multiple myeloma patients, was started. On September 2007, the immune and clinical response evaluation of first four patients was finished.The anticancer vaccine contained dendritic cells loaded with monoclonal immunoglobulin produced by myeloma cells. The immune response detected using ELISpot was observed in 3/4 patients. During the vaccination, no significant toxicities or negative side-effects were observed. The clinical trial is going on with vaccination other patients with multiple myeloma.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.